How to construct analysis of covariance in clinical trials: ANCOVA with one covariate in a completely randomized design structure
Korean Journal of Anesthesiology · 01.08.2025 · 78 (4) · 315-320
DOI: 10.4097/kja.24820 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Korean Journal of Anesthesiology, erschienen am 01.08.2025. Verfasst von WooJin Jung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Medical Informatics, Dongguk University School of Medicine, Goyang, Korea. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Analysis of covariance (ANCOVA) is a statistical method used to assess mean differences between groups by considering factors such as covariates or fixed effects and is often used to assess efficacy endpoints in clinical trials. When performing ANCOVA, the slope of the regression model should be the same for all treatment groups, with no interaction between the group and the covariate. Therefore, before analysis, the significance of the full ANCOVA model with interactions must be tested. If the interaction in the full model is statistically significant, the model that includes the interaction should be used; otherwise, ANCOVA using a reduced model without the interaction should be performed. If the ANCOVA model is not significant, this analysis method is not appropriate and a multivariate analysis or individual regression line estimation can be considered. If the difference in means between the groups is tested by ANCOVA, the confidence interval for the adjusted mean (least-squares mean) should be calculated and tested. Because the results may change depending on the covariates used in the ANCOVA model, the covariates should be predefined before performing the analysis. If a new covariate must be defined after a clinical trial is initiated, it should be specified in the statistical analysis plan. This is considered a major amendment; thus, the covariates must be redefined before clinical trial completion and must be described in the clinical study report. A clear report describing whether the redefinition of the covariates affected the sample size or decision-making is also necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics and Medical Informatics, Dongguk University School of Medicine, Goyang, Korea.
- Department of Preventive Medicine, Dongguk University School of Medicine, Gyeongju, Korea.
- Stroke and Neurovascular Regulation Laboratory, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.
Zitieren
APA
Jung, W., Lee, K., Kim, H. H., & Lim, C. (2025). How to construct analysis of covariance in clinical trials: ANCOVA with one covariate in a completely randomized design structure. Korean Journal of Anesthesiology, 78(4), 315-320. https://doi.org/10.4097/kja.24820
Vancouver
Jung W, Lee K, Kim HH, Lim C. How to construct analysis of covariance in clinical trials: ANCOVA with one covariate in a completely randomized design structure. Korean Journal of Anesthesiology. 2025;78(4):315-320. doi:10.4097/kja.24820
BibTeX
@article{Jung2025,
author = {Jung, WooJin and Lee, Kwan and Kim, Hyung-Hwan and Lim, Chiyeon},
title = {How to construct analysis of covariance in clinical trials: ANCOVA with one covariate in a completely randomized design structure},
journal = {Korean Journal of Anesthesiology},
year = {2025},
volume = {78},
number = {4},
pages = {315--320},
doi = {10.4097/kja.24820}
}
EUVIMED